课题基金 / 基金详情

GYNECOMASTIA--TREATMENT WITH DIHYDROTESTOSTERONE HEPTANOATE

GYNECOMASTIA--TREATMENT WITH DIHYDROTESTOSTERONE HEPTANOATE
男性乳房发育症——庚酸二氢睾酮治疗
批准号：
3763251
负责人：
BRUCE S. KEENAN
金额：
$0.0万
依托单位：
UNIVERSITY OF TEXAS MED BR GALVESTON
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/3763251
关键词：
dihydrotestosterone endocrine pharmacology gynecomastia hormone therapy human subject human therapy evaluation insulin insulinlike growth factor male obesity reproductive system disorder chemotherapy somatotropin

项目摘要

项目成果

BRUCE S. KEENAN的其他基金

相似基金

相关文献

中文摘要
翻译
通过比较肥胖和瘦弱受试者与GCM进一步增加
英文摘要
Uses a comparison of obese and lean subjects with GCM to gain further insight into the mechanisms controlling the growth of fibroglandular tissue in the male and the most appropriate methods of treatment. Hypotheses are that DHT treatment will result in regression of the fibroglandular tissue, will have an equal effect in the two groups, and the development of gynecomastia in lean and obese individuals is independent of differences in circulating levels of GH, IGF1 and insulin.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
NEUROTRANSMITTER REGULATION OF GROWTH HORMONE SECRETION
DIHYDROTESTOSTERONE HEPTANOATE TREATMENT OF GYNECOMASTIA
PINEAL FUNCTION IN CHILDHOOD AND ADOLESCENCE
DIHYDROTESTOSTERONE HEPTANOATE TREATMENT OF GYNECOMASTIA
海外基金